Compare PPIH & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPIH | NVNO |
|---|---|---|
| Founded | 1909 | 1987 |
| Country | United States | United States |
| Employees | N/A | 33 |
| Industry | Pollution Control Equipment | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.3M | 7.2M |
| IPO Year | 1994 | N/A |
| Metric | PPIH | NVNO |
|---|---|---|
| Price | $31.89 | $11.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | ★ 72.9K | 7.8K |
| Earning Date | 04-16-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.61 | N/A |
| EPS | ★ 2.09 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $9.33 | $140.00 |
| P/E Ratio | $15.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.20 | $0.30 |
| 52 Week High | $36.72 | $13.44 |
| Indicator | PPIH | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 55.28 |
| Support Level | $29.22 | $9.81 |
| Resistance Level | $33.42 | $12.69 |
| Average True Range (ATR) | 1.39 | 0.69 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 49.95 | 91.92 |
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.